Carli Vincent, MD
Family Medicine · Concord, NHNPI 1760069918
Payments from drug & device makers
Across 50 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$230
- Pfizer$183
- Collegium Pharmaceutical, Inc.$77
- Merck$76
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$58
- Boehringer Ingelheim$52
- plus $364 from 13 others
What the payments were for
- Food & beverage$1,041100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $230 |
| Pfizer | 9 | $183 |
| Collegium Pharmaceutical, Inc. | 4 | $77 |
| Merck | 3 | $76 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $58 |
| Boehringer Ingelheim | 2 | $52 |
| AstraZeneca | 3 | $50 |
| Novo Nordisk | 2 | $44 |
| Lilly USA, LLC | 2 | $35 |
| Abiomed | 1 | $33 |
| Exact Sciences | 2 | $30 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| Acadia Pharmaceuticals Inc | 1 | $24 |
| Seqirus USA Inc | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Novartis | 1 | $21 |
| GSK | 1 | $19 |
| Viiv Healthcare Company | 1 | $19 |
| Edwards Lifesciences | 1 | $15 |
How this compares
$1,041 in reported general payments places this provider in the 80th percentile of 397 family medicine providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 23 | $2,649 |
| Fluticasone Propionate | 19 | $297 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $271 |
| Gabapentin | 14 | $263 |
| Atorvastatin Calcium | 37 | $252 |
| Amlodipine Besylate | 35 | $199 |
| Trazodone Hcl | 12 | $193 |
| Rosuvastatin Calcium | 23 | $155 |
| Famotidine | 11 | $151 |
| Prednisone | 11 | $142 |
| Metoprolol Succinate | 17 | $111 |
| Metformin Hcl | 12 | $107 |
| ClopidogrelClopidogrel Bisulfate | 14 | $103 |
| Cyclobenzaprine Hcl | 13 | $94 |
| Lisinopril | 29 | $77 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Concord
- Peter LoeserConcord$10K
- Jennifer BadgerConcord$4K
- Mathew SawyerConcord$3K
- Megan SullivanConcord$3K
- Patrick FoxConcord$3K
- Sabrina BolianitesConcord$3K
- Jennifer MackenzieConcord$3K
- Jeffrey CorbettConcord$2K
- Kenneth CallConcord$1K
- Mark BallentynePortsmouth$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.